載入...
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Anlotinib is a multitargeted antiangiogenic drug, and its clinical predictor for responsive non‐small cell lung cancer (NSCLC) patients is still elusive. Here, tumor‐specific target capture is used to profile the circulating DNA of ALTER0303 (evaluating NSCLC clinical antitumor efficacy through anlo...
Na minha lista:
| 發表在: | Adv Sci (Weinh) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774020/ https://ncbi.nlm.nih.gov/pubmed/31592412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201900721 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|